legendbiotech.com (LEGN) - Utang marang Ekuitas

Quote characteristics on GURU.Markets show that the total debt-to-equity ratio for Legend Biotech (LEGN) is 0.23. The business relies on an individualized patient cell modification cycle, creating a unique treatment method. The company's financial model is not subject to the influence of economic downturns or seasonality. Operations strictly comply with sanitary standards, guaranteeing full biological safety during waste disposal.

The total debt-to-equity ratio determines the degree of financial leverage by comparing total liabilities to equity to assess the business's resilience to credit risks. Analyzing the debt-to-equity ratio of Legend Biotech (LEGN) reveals whether the company possesses sufficient resources to maintain costly bioreactor automation while sustaining necessary expenditures for qualified medical personnel.